Study Evaluating rhIL-11 in Active Crohn's Disease

NCT00040521 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Crohn Disease
Inflammatory Bowel Disease

Interventions

DRUG: Recombinant Human Interleukin-11 (rhIL-11)

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer